Funding from a National Science Foundation program will help a team of Texas A&M engineering and public health students take the EASYMASK from concept to market.
Wenshe Ray Liu, the first scientist to identify remdesivir as a potential treatment option, says researchers are pursuing leads on medications to fight SARS-CoV-2.
A team of Texas A&M students is adapting its award-winning sanitization technology. The program provides resources and funding to further the commercialization of student products.